SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DALPIAZ, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.601
AS - Asia 10.400
EU - Europa 5.253
SA - Sud America 1.634
Continente sconosciuto - Info sul continente non disponibili 337
AF - Africa 211
OC - Oceania 27
AN - Antartide 1
Totale 35.464
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.173
SG - Singapore 3.752
CN - Cina 2.485
BR - Brasile 1.251
VN - Vietnam 1.056
IT - Italia 1.050
UA - Ucraina 994
HK - Hong Kong 889
DE - Germania 740
TR - Turchia 597
GB - Regno Unito 545
BD - Bangladesh 420
FR - Francia 378
FI - Finlandia 343
SE - Svezia 305
JP - Giappone 293
IN - India 292
RU - Federazione Russa 258
PL - Polonia 240
CA - Canada 192
MX - Messico 160
AR - Argentina 136
ID - Indonesia 112
NL - Olanda 85
PK - Pakistan 81
CO - Colombia 74
ZA - Sudafrica 67
IQ - Iraq 65
ES - Italia 55
EC - Ecuador 54
AT - Austria 40
CL - Cile 40
UZ - Uzbekistan 38
BE - Belgio 36
LT - Lituania 36
IR - Iran 35
PH - Filippine 34
SA - Arabia Saudita 31
CZ - Repubblica Ceca 30
EG - Egitto 30
TW - Taiwan 29
PY - Paraguay 28
VE - Venezuela 27
MA - Marocco 26
AE - Emirati Arabi Uniti 25
MY - Malesia 25
KR - Corea 23
KE - Kenya 21
TN - Tunisia 20
AU - Australia 17
TH - Thailandia 17
IE - Irlanda 16
JM - Giamaica 16
DZ - Algeria 14
CH - Svizzera 13
CR - Costa Rica 13
NP - Nepal 13
PE - Perù 12
AL - Albania 11
LB - Libano 10
NZ - Nuova Zelanda 10
DO - Repubblica Dominicana 9
ET - Etiopia 9
KZ - Kazakistan 9
RS - Serbia 9
AZ - Azerbaigian 8
BG - Bulgaria 8
IL - Israele 8
JO - Giordania 8
PS - Palestinian Territory 8
RO - Romania 8
GR - Grecia 7
HN - Honduras 7
BA - Bosnia-Erzegovina 6
BO - Bolivia 6
DK - Danimarca 6
HU - Ungheria 6
QA - Qatar 6
CI - Costa d'Avorio 5
KG - Kirghizistan 5
OM - Oman 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
GE - Georgia 4
GT - Guatemala 4
MK - Macedonia 4
NO - Norvegia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BS - Bahamas 3
BY - Bielorussia 3
EU - Europa 3
KW - Kuwait 3
ME - Montenegro 3
MN - Mongolia 3
NG - Nigeria 3
NI - Nicaragua 3
PA - Panama 3
PR - Porto Rico 3
SC - Seychelles 3
Totale 35.089
Salva come PNG Salva come JPEG
Città #
Singapore 2.343
Ashburn 1.842
Woodbridge 1.461
Fairfield 1.340
San Jose 1.142
Houston 1.019
Jacksonville 1.019
Hong Kong 865
Chandler 855
Santa Clara 827
Beijing 715
Ann Arbor 622
Wilmington 559
Seattle 540
Cambridge 480
Ho Chi Minh City 374
Izmir 338
Nanjing 299
Hanoi 271
New York 267
Tokyo 265
Los Angeles 259
Ferrara 247
Princeton 228
Warsaw 226
Dallas 216
Boardman 189
Lauterbourg 188
Council Bluffs 182
Milan 151
The Dalles 150
San Diego 122
Munich 117
Helsinki 110
São Paulo 109
Addison 104
Nanchang 99
Mexico City 95
Orem 81
Shenyang 81
Hefei 77
Shanghai 77
Hebei 74
London 72
Buffalo 71
Chicago 67
Jakarta 65
Tianjin 64
Brooklyn 63
Rio de Janeiro 57
Changsha 56
Toronto 53
Falls Church 49
Montreal 49
Bremen 47
Chennai 47
Frankfurt am Main 47
Moscow 47
Redwood City 46
San Mateo 46
Rome 45
Dearborn 44
Atlanta 43
Da Nang 40
Turku 38
Amsterdam 37
Denver 37
Jiaxing 35
Kunming 35
Phoenix 35
Bologna 34
Falkenstein 34
San Francisco 34
Tashkent 34
Johannesburg 33
Norwalk 33
Stockholm 32
Manchester 30
Ankara 28
Mountain View 28
Boston 27
Haiphong 27
Jinan 27
Belo Horizonte 26
Guangzhou 26
Philadelphia 26
Medellín 25
Poplar 25
Vienna 25
Brussels 24
Dhaka 24
Hải Dương 24
Naples 24
Washington 24
Chongqing 23
Mumbai 23
Nuremberg 23
Zhengzhou 23
Baghdad 21
Salt Lake City 21
Totale 22.768
Salva come PNG Salva come JPEG
Nome #
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 397
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 293
Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 291
Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently? 286
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles 268
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes 263
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 254
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 248
Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? 247
Conjugation of aspirin with vitamin C: uptake and stability studies 242
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 234
Diclofenamic acid-vitamin C conjugates: stability and interaction studies with ascorbate transporters 226
Physicochemical stability of cabazitaxel and docetaxel solutions 226
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity 222
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 222
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 221
A concerted binding study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines to mitochondrial benzodiazepine receptors 220
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 218
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 214
Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles 212
Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents 212
Hyaluronic acid based-hybrid nanoparticles for targeted nose- to-brain delivery of dimethyl fumarate 208
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 206
Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A 1 receptors of LUF5831, a novel nonadenosine-like agonist 206
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 206
Binding thermodynamics at A1 and A2A adenosine receptors 205
An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity. 204
1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one and 5H-pyrazolo[4,3-d] 1,2,3-triazin-4(3H)-one derivatives. Synthesis and in vitro biological activity at adenosine A1 and A2a receptors 204
From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine 204
Can Thermodynamic Measurements of Receptor Binding Yield Information on Drug Affinity and Efficacy? 201
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 201
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 201
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 201
Binding thermodynamics of 5-HT(1A) receptor ligands 200
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 199
Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: Effect of steroids, flavonoids and NSAIDs 197
Conformational Aspects of Human Formyl-peptide Receptor Agonists 196
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 195
Characterization and Hydrolysis Studies of a Prodrug Obtained as Ester Conjugate of Geraniol and Ferulic Acid by Enzymatic Way 194
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 193
Brain targeting of neuroactive drugs: studies of their transport mechanisms as conjugated with vitamin C or glucose. 189
Solid microparticles based on chitosan or methyl-beta-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate 189
Chlorogenic acid permeation across intestinal cell monolayers: influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 189
Conformational aspects of human formylpeptide receptor antagonists 188
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 187
Progress in drug delivery to the central nervous system by the prodrug approach 187
Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? 186
Bile acids modulation of nanoparticle macrophage uptake 186
Dopamine-sensitive adenylyl cyclases in neuronal development: Physiopathological and pharmacological implications 185
Controlled release studies of antiischemic agents encapsulated in poly(lactic acid) nanoparticles. 185
Chlorogenic acid permeation across intestinal cell monolayers: Influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 184
Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration 183
Solid lipid microparticles for the stability enhancement of a dopamine prodrug 182
Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study 182
Binding therodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 180
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 179
Incorporation of the polar antiischemic drug N6-cyclopentyladenosine in solid lipid microparticles 178
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 177
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 176
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 175
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 175
Adenosine analogs prodrugs: design, synthesis and chemico-physical characterization of N6-cyclopentyladenosine (CPA) derivatives 174
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: Thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors 174
Binding thermodynamics of adenosine A2a receptor ligands 174
Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in-vivo preclinical pharmacokinetic study 174
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment 173
Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight 172
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 171
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 170
Poly(lactic acid) microspheres for the sustained release of antiischemic agents 168
Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review 168
Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor 166
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 166
Effects of Microencapsulated Ferulic Acid or Its Prodrug Methyl Ferulate on Neuroinflammation Induced by Muramyl Dipeptide 165
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres 164
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 164
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 163
Design and formulation of Eudragit-coated zein/pectin nanoparticles for the colon delivery of resveratrol 163
Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance? 161
Caffeine intake induces an alteration of human neutrophils A2A adenosine receptors. 160
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 160
A Novel Conjugated Agent between Dopamine and an A(2A) Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach. 160
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 159
Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells 159
Peptide derivatives as agonists or antagonists of formylpeptide receptors: analysis of their effects on neutrophils 158
Determination of the adenosine A1 agonist N6-cyclopentyladenosine in rat blood by solid-phase extraction and HPLC 158
Drug release from pharmaceutical co-crystals: Are therapeutic and safety properties of active pharmaceutical substances retained? 158
Full and partial agonists and thermodynamic binding parameters of adenosine A1 receptor ligands 157
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 157
From crystal to solution and across the membranes: the case of carbamazepine co-crystals 157
Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System? 156
Exploring the Use of Spray Congealing to Produce Solid Dispersions with Enhanced Indomethacin Bioavailability 156
Adenosine A1 receptor: Analysis of the potential therapeutic effects obtained by its activation in the central nervous system 156
Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors 155
Nasal administration and brain targeting of an antiischemic agent 154
Uptake and stability studies of diclofenamic acid and its pro-drug obtained by conjugation with vitamin C 153
Coniugati dell’acido ascorbico ad attività neurotropica. 153
Materie Prime: Eccipienti 152
Temperature dependence and GABA modulation of β-carboline binding to rat cerebellum benzodiazepine receptors 152
Risedronate pharmacokinetic studies after oral administration to rats of loaded TiO2 nanoparticles 151
Totale 19.190
Salva come PNG Salva come JPEG
Categoria #
all - tutte 156.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.588
Totale 159.683
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.984 50 229 148 121 88 85 77 105 76 164 182 659
2022/20231.979 227 94 53 256 380 308 59 156 250 15 115 66
2023/2024994 121 133 57 24 94 111 35 39 15 19 33 313
2024/20254.803 98 91 382 190 613 431 192 295 726 583 712 490
2025/202613.791 1.245 583 1.173 1.706 1.767 842 1.474 813 1.420 1.585 660 523
2026/2027525 525 0 0 0 0 0 0 0 0 0 0 0
Totale 35.464